Recent studies have revealed the anti-tumor effects of TSN on various human cancer cells such as osteosarcoma, lung cancer, and colorectal cancer [9–12] by modulating mitogen-activated protein kinases pathway, epithelial–mesenchymal transition, and estrogen receptor β. The gene discussed is TSN; the disease is lung cancer.